Related Experiment Video
Updated: Jun 27, 2026
10:01
Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Improving the interaction of Myc-interfering peptides with Myc using molecular dynamics simulations
Eva M Jouaux1, Barbara B Timm, Katja M Arndt
1Department of Biology, Albert-Ludwigs University Freiburg, D-79104 Freiburg, Germany.
Summary
Researchers optimized a Myc-interfering peptide (Mip) to inactivate the Myc:Max complex. Computational studies identified high-affinity mutants, advancing targeted cancer therapy development.
Area of Science:
- Biochemistry
- Molecular Biology
- Computational Chemistry
Background:
- The Myc:Max complex is a key regulator of gene expression implicated in various cancers.
- A Myc-interfering peptide (Mip) was previously developed for Myc:Max complex inactivation.
- Targeted inhibition of Myc is a promising therapeutic strategy.
Purpose of the Study:
- To computationally define the contribution of amino acids in the Myc:Mip coiled coil domain.
- To optimize Mip for enhanced binding affinity and Myc inactivation.
- To validate computational findings with experimental data.
Main Methods:
- Molecular dynamics simulations.
- Free energy calculations using the molecular mechanics Generalized Born Surface Area (GBSA) method.
- Introduction and analysis of point mutations in the Mip peptide.
Main Results:
- Detailed analysis of amino acid contributions in the Myc:Mip coiled coil domain.
- Identification of two Mip mutants with significantly higher binding affinities.
- Computational results showed strong agreement with experimental findings.
Conclusions:
- The identified Mip mutants demonstrate high potential for Myc inactivation.
- These optimized mutants serve as a foundation for further therapeutic development.
- The presented computational and experimental protocols facilitate future Mip optimization.
